Related Experiment Videos
Semisynthesis of cytotoxic proteins using a modified protein splicing element
Protein Science : a Publication of the Protein Society
|November 25, 1998
Summary
A novel semisynthetic protein ligation method enables the efficient production of cytotoxic proteins like ribonuclease A (RNase A) and HpaI. This technique uses inteins to create reactive thioesters, ligating synthetic peptides to truncated proteins, restoring full catalytic activity and allowing unnatural amino acid insertion.
Area of Science:
- Biochemistry
- Molecular Biology
- Protein Engineering
Background:
- Traditional methods for producing complex proteins can be challenging.
- Cytotoxic proteins like RNase A and HpaI have therapeutic and research applications.
- Intein-mediated protein ligation offers a potential solution for protein synthesis.
Purpose of the Study:
- To develop and validate a novel semisynthetic approach for producing cytotoxic proteins.
- To demonstrate the efficacy of intein-mediated ligation for generating full-length, active enzymes.
- To explore the potential for incorporating unnatural amino acids using this method.
Main Methods:
- Utilized a semisynthetic strategy involving protein splicing elements (inteins).
- Generated reactive C-terminal thioesters on truncated recombinant proteins (RNase A and HpaI).
- Ligated synthetic peptides to truncated proteins via nucleophilic attack, forming native peptide bonds.
Main Results:
- Successfully produced full-length bovine pancreatic ribonuclease A (RNase A) and HpaI restriction endonuclease.
- Ligated proteins exhibited catalytic activity comparable to wild-type enzymes.
- RNase A demonstrated turnover numbers and Km values consistent with literature.
- HpaI showed specific activity within the expected range.
Conclusions:
- The novel semisynthetic ligation technique is effective for producing active cytotoxic proteins.
- This method provides a robust platform for protein engineering, including the insertion of unnatural amino acids.
- The approach offers advantages for producing complex or modified proteins.